Transcending the Pharmaceutical Barriers in Hong Kong While the Hong Kong pharmaceutical industry is going through internal structural changes, it has been discovering with regularity, firms emerging which address the mashup customer journeys challenging them. Besides the various inequalities at the public regulatory system and the supply chain disorder, which are the most essential problems to solve, the industry emerges as a player which has to use other, far more powerful, operational tools than high-performance point-of-sale (POS) systems. In spite of such risk, the need for a high-performance POS system [...]
Continue Reading